Business Context and Reporting Period
Company: International Paper Company
Filing Type: Form 8-K (Current Report)
Date of Report: August 20, 2025
Event: Entry into a Material Definitive Agreement to sell the Global Cellulose Fibers (GCF) business.
Key Financial Metrics and Transaction Details
- Transaction Value: $1.5 billion purchase price (subject to closing adjustments).
- Payment Structure: Includes issuance of preferred stock with an aggregate initial liquidation preference of $190 million.
- Impairment Charge: Expected non-cash impairment charge between $700 million and $900 million.
- Accounting Treatment: GCF business to be classified as "held for sale" and treated as a discontinued operation in the quarter ending September 30, 2025.
- Termination Fee: $85 million payable by the Buyer under specified termination circumstances.
Material Changes and Strategic Shifts
The Company has entered into a Securities Purchase Agreement to divest its entire Global Cellulose Fibers (GCF) business. This represents a significant strategic contraction of the Company's portfolio. The transaction involves the sale of equity interests in GCF US Holdings LLC, GCF (Asia) Limited, International Paper Cellulose Fibers (Poland), and International Paper Canada Pulp Holdings ULC.
Guidance, Outlook, and Risks
- Closing Conditions: Subject to customary conditions, including regulatory approvals under the Hart-Scott-Rodino Act and the Competition Act (Canada).
- Timeline: The "End Date" for closing is February 20, 2026. This may be extended to May 20, 2026, if delays are due solely to pending competition approvals.
- Management Changes: Clayton R. Ellis, Senior Vice President – Global Cellulose Fibers, is expected to depart International Paper upon closing to assume a position at the GCF business.
- Risks: Risks include failure to obtain regulatory approvals, termination of the agreement, unexpected costs, and the potential for the final impairment charge to differ from the current estimate.
Investor Verification Checklist
- Verify the final closing date and whether the transaction closes before the February 20, 2026 deadline.
- Monitor the Q3 2025 Form 10-Q for the precise amount of the non-cash impairment charge (currently estimated at $700M–$900M).
- Confirm receipt of all necessary antitrust and competition law approvals in the US and Canada.
- Review the full text of the Sale Agreement (to be filed in the Q3 2025 Form 10-Q) for specific representations and warranties.
- Assess the impact of the discontinued operation classification on future earnings guidance and segment reporting.